- Home
- ACMR vs SLNO Comparison
ACMR vs SLNO Comparison
Compare ACMR & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACMR | SLNO |
|---|---|---|
| Founded | 1998 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.5B |
| IPO Year | 2017 | 2014 |
Fundamental Metrics
Financial Performance| Metric | ACMR | SLNO |
|---|---|---|
| Price | $43.72 | $46.21 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 10 |
| Target Price | $43.00 | ★ $110.90 |
| AVG Volume (30 Days) | 1.2M | ★ 1.3M |
| Earning Date | 11-05-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 29.16 | N/A |
| EPS | ★ 1.72 | N/A |
| Revenue | ★ $880,350,000.00 | $98,675,000.00 |
| Revenue This Year | $18.22 | N/A |
| Revenue Next Year | $16.80 | $155.86 |
| P/E Ratio | $22.89 | ★ N/A |
| Revenue Growth | ★ 20.77 | N/A |
| 52 Week Low | $14.93 | $41.50 |
| 52 Week High | $45.12 | $90.32 |
Technical Indicators
Market Signals| Indicator | ACMR | SLNO |
|---|---|---|
| Relative Strength Index (RSI) | 69.58 | 38.04 |
| Support Level | $39.29 | $45.07 |
| Resistance Level | $43.78 | $49.75 |
| Average True Range (ATR) | 2.05 | 2.00 |
| MACD | 0.28 | -0.12 |
| Stochastic Oscillator | 90.05 | 14.85 |
Price Performance
Historical ComparisonAbout ACMR ACM Research Inc.
ACM Research Inc supplies advanced, innovative capital equipment developed for the world-wide semiconductor industry. Fabricators of advanced integrated circuits, or chips, can use its wet-cleaning and other front-end processing tools in numerous steps to improve product yield, even at increasingly advanced process nodes. It has designed these tools for use in fabricating foundry, logic and memory chips, including dynamic random-access memory, or DRAM, and 3D NAND-flash memory chips. The company also develops, manufactures and sells advanced packaging tools to wafer assembly and packaging customers.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.